Santa Cruz Biotechnology offers a broad range of FBXW17 monoclonal antibodies for investigating FBXW17 protein function. FBXW17 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FBXW17, a member of the F-box protein family, plays a crucial role in the ubiquitin-proteasome pathway, which is essential for regulating protein degradation and maintaining cellular homeostasis. FBXW17 is involved in various cellular processes, including cell cycle regulation and signal transduction, making it significant in cancer research and other diseases. Understanding FBXW17 function can provide insights into its potential as a therapeutic target. FBXW17 monoclonal antibodies are available with multiple conjugation options, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC). Extensive quality control measures ensure consistent and reliable results across experimental applications. Santa Cruz Biotechnology monoclonal antibodies targeting FBXW17 enable researchers worldwide to advance their understanding of cellular processes and disease mechanisms.